HK1106445A1 - Melanocortin receptor binding mimetibodies, compositions, methods and uses - Google Patents

Melanocortin receptor binding mimetibodies, compositions, methods and uses

Info

Publication number
HK1106445A1
HK1106445A1 HK07112011.3A HK07112011A HK1106445A1 HK 1106445 A1 HK1106445 A1 HK 1106445A1 HK 07112011 A HK07112011 A HK 07112011A HK 1106445 A1 HK1106445 A1 HK 1106445A1
Authority
HK
Hong Kong
Prior art keywords
methods
receptor binding
compositions
melanocortin receptor
mimetibodies
Prior art date
Application number
HK07112011.3A
Other languages
English (en)
Inventor
Mark Cunningham
Vedrana Stojanovic-Susulic
Karyn O'neil
Chichi Huang
Jeffrey Luo
Original Assignee
Janssen Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Biotech Inc filed Critical Janssen Biotech Inc
Publication of HK1106445A1 publication Critical patent/HK1106445A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/68—Melanocyte-stimulating hormone [MSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1796—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK07112011.3A 2004-10-25 2007-11-05 Melanocortin receptor binding mimetibodies, compositions, methods and uses HK1106445A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62196004P 2004-10-25 2004-10-25
PCT/US2005/038431 WO2006047535A2 (fr) 2004-10-25 2005-10-25 Corps mimetiques de liaison au recepteur de la melanocortine, compositions, procedes et utilisations

Publications (1)

Publication Number Publication Date
HK1106445A1 true HK1106445A1 (en) 2008-03-14

Family

ID=36228385

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07112011.3A HK1106445A1 (en) 2004-10-25 2007-11-05 Melanocortin receptor binding mimetibodies, compositions, methods and uses

Country Status (29)

Country Link
US (1) US20060105951A1 (fr)
EP (1) EP1812046B1 (fr)
JP (1) JP2008517605A (fr)
KR (1) KR101255140B1 (fr)
CN (1) CN101437540B (fr)
AT (1) ATE501731T1 (fr)
AU (1) AU2005299440B2 (fr)
BR (1) BRPI0518411A2 (fr)
CA (1) CA2585287A1 (fr)
CY (1) CY1111486T1 (fr)
DE (1) DE602005026970D1 (fr)
DK (1) DK1812046T3 (fr)
EA (1) EA200700944A1 (fr)
EC (1) ECSP077416A (fr)
ES (1) ES2363023T3 (fr)
HK (1) HK1106445A1 (fr)
HR (1) HRP20110405T1 (fr)
IL (1) IL182683A0 (fr)
MA (1) MA28943B1 (fr)
ME (1) ME01234B (fr)
MX (1) MX2007004974A (fr)
NO (1) NO20072499L (fr)
PL (1) PL1812046T3 (fr)
PT (1) PT1812046E (fr)
RS (1) RS51789B (fr)
SI (1) SI1812046T1 (fr)
TN (1) TNSN07157A1 (fr)
WO (1) WO2006047535A2 (fr)
ZA (1) ZA200704260B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7910101B2 (en) * 2004-10-25 2011-03-22 Centocor, Inc. Melanocortin receptor binding mimetibodies, compositions, methods and uses
US7790671B2 (en) 2005-10-07 2010-09-07 Codman & Shurtleff, Inc. Implantable pump for protein delivery for obesity control by drug infusion into the brain
MX2010013436A (es) 2008-06-09 2011-06-21 Palatin Technologies Inc Peptidos especificos del receptor de melanocortina para el tratamiento de disfuncion sexual.
US20090305960A1 (en) * 2008-06-09 2009-12-10 Palatin Technologies, Inc Melanocortin Receptor-Specific Peptides for Treatment of Obesity / 669
US8614185B2 (en) * 2009-05-04 2013-12-24 Centocor Ortho Biotech Inc. Fusion proteins of alpha-MSH derivatives and Fc
BRPI1009644B1 (pt) 2009-06-08 2022-02-08 Palatin Technologies, Inc Peptídeo cíclico ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica e uso da composição farmacêutica
EP2440572B1 (fr) 2009-06-08 2017-04-05 Palatin Technologies, Inc. Peptides spécifiques des récepteurs aux mélanocortines à pont lactame
UY32690A (es) 2009-06-08 2011-01-31 Astrazeneca Ab Péptidos específicos para receptores de melanocortina
EP2504351A4 (fr) 2009-11-23 2013-10-30 Palatin Technologies Inc Peptides linéaires spécifiques du récepteur de la mélanocortine-1
NZ599774A (en) 2009-11-23 2014-11-28 Palatin Technologies Inc Melanocortin-1 receptor-specific cyclic peptides
JP2020141710A (ja) * 2011-07-06 2020-09-10 ゲンマブ エー／エス 抗体重鎖のｃ末端の修飾による補体依存性細胞傷害の調節
WO2020177627A1 (fr) * 2019-03-02 2020-09-10 上海一宸医药科技有限公司 Anticorps bispécifique

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1137340A4 (fr) * 1998-12-09 2005-12-21 Eleanor Roosevelt Inst Composition et procedes de regulation du poids corporel et des pathologies associees
US7169603B2 (en) * 2000-07-14 2007-01-30 Mgi Pharma Biologics, Inc. α-MSH related compounds and methods of use
WO2004002424A2 (fr) * 2002-06-28 2004-01-08 Centocor, Inc. Corps mimetiques d'epo de mammifere a deletion ch1, compositions, methodes et utilisations associees
WO2004002417A2 (fr) * 2002-06-28 2004-01-08 Centocor, Inc. Corps mimetiques mammaliens a deletion ch1, compositions, procedes et utilisations
KR20070004078A (ko) * 2004-03-31 2007-01-05 센토코 인코포레이티드 인간 ｇｌｐ-1 모방체, 조성물, 방법 및 용도

Also Published As

Publication number Publication date
JP2008517605A (ja) 2008-05-29
ZA200704260B (en) 2009-03-25
ECSP077416A (es) 2007-05-30
CN101437540B (zh) 2012-12-19
CY1111486T1 (el) 2015-08-05
EA200700944A1 (ru) 2008-04-28
PT1812046E (pt) 2011-06-28
US20060105951A1 (en) 2006-05-18
PL1812046T3 (pl) 2011-08-31
DE602005026970D1 (de) 2011-04-28
RS51789B (en) 2011-12-31
EP1812046B1 (fr) 2011-03-16
SI1812046T1 (sl) 2011-06-30
EP1812046A4 (fr) 2009-11-11
ME01234B (fr) 2013-06-20
BRPI0518411A2 (pt) 2008-11-18
CA2585287A1 (fr) 2006-05-04
CN101437540A (zh) 2009-05-20
WO2006047535A3 (fr) 2008-09-04
MA28943B1 (fr) 2007-10-01
IL182683A0 (en) 2007-09-20
TNSN07157A1 (en) 2008-11-21
WO2006047535A2 (fr) 2006-05-04
AU2005299440B2 (en) 2011-12-15
KR101255140B1 (ko) 2013-04-22
NO20072499L (no) 2007-07-16
ATE501731T1 (de) 2011-04-15
HRP20110405T1 (hr) 2011-06-30
ES2363023T3 (es) 2011-07-19
EP1812046A2 (fr) 2007-08-01
AU2005299440A1 (en) 2006-05-04
DK1812046T3 (da) 2011-06-06
KR20070085416A (ko) 2007-08-27
MX2007004974A (es) 2007-10-17

Similar Documents

Publication Publication Date Title
TNSN07157A1 (en) Melanocortin receptor binding mimetibodies, compositions, methods and uses
WO2007041635A3 (fr) Variants de fc dotés de propriétés de liaison aux récepteurs fc optimisées
WO2007014169A3 (fr) Anticorps anti-cd26 et methodes d'utilisation de ces derniers
IL258718A (en) Human anti-23-il antibodies, preparations, methods and uses
WO2006105338A3 (fr) Variants fc presentant des proprietes optimisees
TW200611910A (en) Interferon-alpha polypeptides and conjugates
WO2006017538A3 (fr) Proteines de liaison a la proteine hk1
MX348735B (es) Celulas madre mesenquimales que expresan los receptores tnf-alfa.
TW200631594A (en) Toll like receptor 3 antagonists, methods and uses
IL189555A0 (en) Compositions of cells enriched for combinations of various stem and progenitor cell populations, methods of use thereof and methods of private banking thereof
WO2007044083A3 (fr) Polypeptides d'interferon-alpha mis au point genetiquement
MX2010007716A (es) Combinacion de una proteina de fusion del anticuerpo-il-2 de anti-edb fibronectina y una molecula que se une a celulas b, progenitores de la celula b y/o sus contrapartes cancerigenas.
MX2008000230A (es) Proteinas de enlace il-6.
EP1617802A4 (fr) Polynucleotides specifiques de cngh0010, polypeptides, anticorps, compositions, methodes et utilisations
TW200711846A (en) Composite materials and methods of making the same
EP1907533A4 (fr) Cellules progénitrices et leurs utilisations
WO2007056760A3 (fr) Recepteurs des lymphocytes t reactifs au virus de l'hepatite c
EP1828237A4 (fr) Gene suppresseur du cancer humain, proteine codee dans ce gene, vecteur d'expression contenant ce gene et cellule transformee par ce vecteur
SG158098A1 (en) Toll like receptor 3 antagonists, methods and uses
EP1844065A4 (fr) Polypeptide possédant une fonction liée à la biosynthèse de la pyridoxine, polynucléotide codant pour ce polypeptide et leurs applications
WO2005082088A3 (fr) Genomique fonctionnelle et piegeage de genes dans des cellules haploides ou hypodiploides

Legal Events

Date Code Title Description
AM Amended specification (according sect 146 of patent law)

Free format text: CORRECTION OF THE NAME OF APPLICANT FROM JANSSEN BIOTECH INC. TO JANSSEN BIOTECH, INC..

Effective date: 20111116

PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20171025